These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 16696641)
61. Hybridization and emergence of virulence in opportunistic human yeast pathogens. Mixão V; Gabaldón T Yeast; 2018 Jan; 35(1):5-20. PubMed ID: 28681409 [TBL] [Abstract][Full Text] [Related]
62. [Assessment of the pathogenicity of various species of Cryptococcus in normal and cortisone-treated mice]. Tuttobello L; De Bernardis F; Morelli L; Fratoni F; Palliola E Ann Ist Super Sanita; 1982; 18(3):489-92. PubMed ID: 7187835 [No Abstract] [Full Text] [Related]
63. Cryptococcus meningitis. GETTELFINGER WC J Ky State Med Assoc; 1958 Nov; 56(11):1112-3. PubMed ID: 13588160 [No Abstract] [Full Text] [Related]
64. [Cryptococcus]. Ikeda R Med Mycol J; 2011; 52(3):199-203. PubMed ID: 21891981 [No Abstract] [Full Text] [Related]
65. When is the Cryptococcus dangerous? Castellani A Lancet; 1969 Sep; 2(7621):648. PubMed ID: 4185623 [No Abstract] [Full Text] [Related]
66. Elucidation of the Role of 3-Hydroxy Fatty Acids in Madu UL; Ogundeji AO; Pohl CH; Albertyn J; Sebolai OM Front Microbiol; 2017; 8():765. PubMed ID: 28491059 [TBL] [Abstract][Full Text] [Related]
67. Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs. Ogundeji AO; Pohl CH; Sebolai OM Antimicrob Agents Chemother; 2016 Aug; 60(8):4799-808. PubMed ID: 27246782 [TBL] [Abstract][Full Text] [Related]
68. Cryptococcal 3-Hydroxy Fatty Acids Protect Cells Against Amoebal Phagocytosis. Madu UL; Ogundeji AO; Mochochoko BM; Pohl CH; Albertyn J; Swart CW; Allwood JW; Southam AD; Dunn WB; May RC; Sebolai OM Front Microbiol; 2015; 6():1351. PubMed ID: 26696972 [TBL] [Abstract][Full Text] [Related]
69. Microsatellite typing of clinical and environmental Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages. Illnait-Zaragozi MT; Martínez-Machín GF; Fernández-Andreu CM; Boekhout T; Meis JF; Klaassen CH PLoS One; 2010 Feb; 5(2):e9124. PubMed ID: 20161737 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of the experimental inoculation of Cryptococcus albidus and Cryptococcus laurentii in normal mice: virulence factors and molecular profile before and after animal passage. Pedroso RS; Ferreira JC; Lavrador MA; Maffei CM; Candido RC Mycopathologia; 2009 Aug; 168(2):59-72. PubMed ID: 19363657 [TBL] [Abstract][Full Text] [Related]
71. Synthesis of cell envelope glycoproteins of Cryptococcus laurentii. Schutzbach J; Ankel H; Brockhausen I Carbohydr Res; 2007 May; 342(7):881-93. PubMed ID: 17316583 [TBL] [Abstract][Full Text] [Related]
72. [Cryptococcus neoformans infections in patients infected and not infected with HIV]. Miró Meda JM; Mallolas Masferrer J; Moreno-Camacho A; Marco Reverter F; García Alcaide F Rev Clin Esp; 1997 Apr; 197 Suppl 1():49-59. PubMed ID: 9297207 [No Abstract] [Full Text] [Related]
73. [Guidelines in cryptococcosis--2008]. Moretti ML; Resende MR; Lazéra MS; Colombo AL; Shikanai-Yasuda MA Rev Soc Bras Med Trop; 2008; 41(5):524-44. PubMed ID: 19009203 [No Abstract] [Full Text] [Related]
74. Cryptococcus within a urinary cast. Poloni JA; Rotta LN; Voegeli CF; Pasqualotto AC Kidney Int; 2013 Jul; 84(1):218. PubMed ID: 23812371 [No Abstract] [Full Text] [Related]
75. Cryptococcus: the once-sleeping giant is fully awake. Levitz SM; Boekhout T FEMS Yeast Res; 2006 Jun; 6(4):461-2. PubMed ID: 16696641 [No Abstract] [Full Text] [Related]